Pancreatic Cancer Research

ResearcherNational Institutes of HealthActive in the last 2 years

Jun Zhong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3700-9434; OpenAlex author ID A5058056521, A5134403989. Sources: OpenAlex.

Their work

Papers
14 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 2 papers · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 2 papers · 2026: 4 papers

Papers 14

  1. Polygenic scores for risk of pancreatic ductal adenocarcinoma: evaluation of novel and published models. Co-author DOI 10.1038/s41698-026-01479-x↗
  2. Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. Co-author DOI 10.1093/jnci/djaf308↗
  3. Characterization of a pancreatic cancer GWAS signal suggests PDX1 buffers stress in the exocrine pancreas Co-author DOI 10.64898/2026.04.13.26350790↗
  4. Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals Co-author DOI 10.64898/2026.04.21.26351329↗
  5. Allelic effects on KLHL17 expression underlie a pancreatic cancer genome-wide association signal at chr1p36.33. Co-author DOI 10.1038/s41467-025-59109-2↗
  6. Large-scale multiomic analysis identifies non-coding somatic driver mutations and nominates ZFP36L2 as a driver gene for pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/gutjnl-2025-335152↗
  7. Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-24-0096↗
  8. Artificial intelligence and improved early detection for pancreatic cancer Co-author DOI 10.1016/j.xinn.2023.100457↗
  9. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Co-author DOI 10.1158/1055-9965.epi-23-0453↗
  10. A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer. First author DOI 10.1016/j.ajhg.2021.09.002↗
  11. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Co-author DOI 10.1093/ajcn/nqab217↗
  12. Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer. Co-author DOI 10.1038/s41467-020-16711-w↗
  13. A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djz246↗
  14. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/s41467-018-02942-5↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Laufey Thora Amundadottir · 3 shared papers, 2023–2026 · strength 0.75
  2. Jason W. Hoskins · 2 shared papers, 2025–2026 · strength 0.45
  3. Katelyn E. Connelly · 2 shared papers, 2025–2026 · strength 0.45
  4. H. Efsun Arda · 2 shared papers, 2025–2026 · strength 0.45
  5. Minal B. Patel · 2 shared papers, 2025–2026 · strength 0.45
  6. Ashley A. Jermusyk · 1 shared paper, 2025 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.